Non-steroidal mineralocorticoid receptor antagonist, finerenone, attenuates obesity- and hypertension-induced cardiomyocyte hypertrophy in a blood pressure-independent manner

Authors: K Morikawa, Y Arima, A Fujiyama, T Yamada, S Hanatani, E Yamamoto, K Tsujita

Published: 2023-11-11

DOI: 10.1093/eurheartj/ehad655.966

Source: Full article